Key Insights

Highlights

Treatment Research

2 treatments under study, led by Saline Injection

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02081326Phase 2Active Not RecruitingPrimary

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

Showing all 1 trials

Research Network

Common Treatments

  • Saline Injection1
  • Bacillus Calmetteguérin1

Active Sponsors

  • Massachusetts General Hospital1

Top Investigators

Related Conditions

  • Covid191
  • Autoimmune Diabetes1
  • Diabetes Mellitus Type I1

Activity Timeline